Teva Pharmaceutical Industries Ltd.
Fact box:
- Founded: 1901 (origins in Jerusalem)
- HQ: Tel Aviv, Israel
- Listings: NYSE: TEVA (ADR); TASE: TEVA
- Sector: Pharmaceuticals (generic and branded)
Teva Pharmaceutical Industries operates as one of the major generic pharmaceutical operators globally and one of the largest Israeli industrial companies. With operating history dating to 1901, Teva represents one of the longest-tenured continuously operating Israeli commercial entities.
The company operates substantial generic-pharmaceutical manufacturing capacity globally alongside the branded-pharmaceutical portfolio anchored by Copaxone (glatiramer acetate, for multiple sclerosis treatment) and adjacent branded products. The company has faced substantial commercial challenges through the 2010s and 2020s related to the generic-pharmaceutical pricing environment, the post-2017 management transition, and the broader operating-margin environment.
Teva's institutional position in Israeli economic history is substantial. The company's manufacturing footprint, employment base, and broader operating activity has anchored Israeli pharmaceutical-sector activity for over a century.
Coverage in The Olam:
/diaspora-investment/israeli-adr-universe//real-economy/